Walejko, Jacquelyn M.
Christopher, Bridgette A.
Crown, Scott B. http://orcid.org/0000-0002-1983-2101
Zhang, Guo-Fang
Pickar-Oliver, Adrian
Yoneshiro, Takeshi
Foster, Matthew W. http://orcid.org/0000-0003-0212-2346
Page, Stephani
van Vliet, Stephan http://orcid.org/0000-0001-8992-555X
Ilkayeva, Olga http://orcid.org/0000-0002-9779-0883
Muehlbauer, Michael J.
Carson, Matthew W.
Brozinick, Joseph T.
Hammond, Craig D.
Gimeno, Ruth E.
Moseley, M. Arthur
Kajimura, Shingo http://orcid.org/0000-0003-0672-5910
Gersbach, Charles A. http://orcid.org/0000-0003-1478-4013
Newgard, Christopher B. http://orcid.org/0000-0002-1293-691X
White, Phillip J. http://orcid.org/0000-0002-0957-425X
McGarrah, Robert W. http://orcid.org/0000-0001-6693-7152
Funding for this research was provided by:
American Diabetes Association (1-21-CMF-005, 1-16-INI-17)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32HL7101-39, 5F32HL137398, K08HL135275)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (1P30DK124723-01, 1P30DK124723-01, 1P30DK124723-01)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
American Heart Association (16SFRN31800000, 16SFRN31800000)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | National Institutes of Health (R01DK097441)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 17 April 2020
Accepted: 18 February 2021
First Online: 15 March 2021
Competing interests
: M.W.C., J.T.B., C.D.H., and R.E.G. are employees of Eli Lilly & Co. C.B.N. is a member of the Eli Lilly Global Diabetes Advisory Board. A portion of the work described herein was funded by a sponsored research agreement from Eli Lilly and Co. to C.B.N. The remaining authors declare no competing interests.